As observed before, the combined treatment led to an increase of tumor-infiltrating CD8+ T cells, a reduction in the proportion of Treg cells and a significant increase of the CD8+/Treg cell ratio (Fig. 6B; Supplementary Fig. S8B). This evidence concerns the gene CD8A and neoplasm.